Table 1.
Clinical characteristics of study groups
| Characteristics | PD n = 24 pts (min-median-max) |
HD n = 27 pts (min-median-max) |
n = 51 pts (min-median-max) | Mann–Whitney U test p value |
|---|---|---|---|---|
| Age (years) | 76.88 ± 3.62 (71-77-82) | 78.00 ± 3.67 (71-78-86) | 77.47 ± 3.65 (71-77-86) | 0.320 |
| Gender (M/F) | 5/19 (20.8 %/79.2 %) | 14/13 (51.9 %/48.9 %) | 19/32 (27.3 %/62.7 %) | |
| BMI (kg/m2) | 26.26 ± 3.97 (19.4-26.3-32.9) | 26.22 ± 4.57 (16.8-26.1-37.8) | 26.24 ± 4.26 (16.8-26.1-37.8) | 0.917 |
| Duration of dialysis (months) | 18.79 ± 17.95 (2-15.5-80) | 19.00 ± 13.42 (2-17-50) | 18.90 ± 15.56 (2-16-80) | 0.467 |
| Systolic BP (mmHg) | 127.42 ± 14.91 (100-122.5-158) | 131.48 ± 14.92 (90-130-160) | 129.57 ± 14.91 (90-130-160) | 0.148 |
| Diastolic BP (mmHg) | 76.92 ± 9.09 (60-77.5-94) | 79.63 ± 8.31 (60-80-95) | 78.35 ± 8.71 (60-80-95) | 0.232 |
| Residual diuresis (ml/24 h) | 642.50 ± 510.25 (0-650-1500) | 564.81 ± 317.08 (0-500-1200) | 601.37 ± 416.62 (0-600-1500) | 0.691 |
| Hb (g/dl) | 11.33 ± 1.11 (9.4-11.25-13.9) | 11.48 ± 1.29 (8.8-11.7-13.7) | 11.41 ± 1.20 (8.8-11.5-13.9) | 0.286 |
| CRP (mg/l) | 13.78 ± 20.07 (1-5.3-72.3) | 11.42 ± 13.73 (0.6-5.7-59.7) | 12.53 ± 16.87 (0.6-5.6-72.3) | 0.858 |
| IL-6 (pg/ml) | 10.22 ± 7.64 (1.8-7.7-27.52) | 7.61 ± 5.31 (1.7-5.2-19.5) | 8.84 ± 6.57 (1.7-7-27.5) | 0.299 |
| Serum albumin (g/dl) | 3.48 ± 0.43 (2.5-3.6-4) | 3.84 ± 0.50 (2.9-3.8-4.9) | 3.67 ± 0.50 (2.5-3.7-4.9) | 0.026* |
| Cholesterol (mmol/l) | 6.17 ± 1.20 (4-5.88-9) | 4.48 ± 1.19 (1.8-4.5-7.5) | 5.27 ± 1.46 (1.8-5.27-9) | 0.000* |
| Pro-ANP (nmol/l) 1–98 | 25.54 ± 13.08 (5.65-24.34-57.25) | 24.28 ± 13.72 (4.55-23.8-67.23) | 24.87 ± 13.30 (4.5-23.8-67.2) | 0.699 |
| NT-proBNP (nmol/l) 1–76 | 0.28 ± 0.19 (0.056-0.2-0.82) | 0.30 ± 0.37 (0.035-0.15-1.98) | 0.29 ± 0.30 (0.035-0.20-1.98) | 0.312 |
| Primary diagnosis | PD/HD | n = 51 pts |
|---|---|---|
| Diabetes mellitus | 10 (41.67 %)/16 (59.26 %) | 26 (51 %) |
| Hypertensive nephropathy | 8 (33.33 %)/6 (22.22 %) | 14 (27.4 %) |
| Interstitial nephropathy | 4 (16.67 %)/2 (7.41 %) | 6 (11.8 %) |
| Chronic glomerular disease | 2 (8.33 %)/1 (3.70 %) | 3 (5.9 %) |
| Polycystic kidney disease | 0 (0 %)/2 (7.41 %) | 2 (3.9 %) |
* p < 0.05, statistically significant; ** 0.05 < p < 0.1